Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13


The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.

van Keimpema M, Grüneberg LJ, Schilder-Tol EJ, Oud ME, Beuling EA, Hensbergen PJ, de Jong J, Pals ST, Spaargaren M.

Haematologica. 2017 Mar;102(3):573-583. doi: 10.3324/haematol.2016.156455. Epub 2016 Dec 1.


N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.

Brown PJ, Gascoyne DM, Lyne L, Spearman H, Felce SL, McFadden N, Chakravarty P, Barrans S, Lynham S, Calado DP, Ward M, Banham AH.

Haematologica. 2016 Jul;101(7):861-71. doi: 10.3324/haematol.2016.142141. Epub 2016 Apr 7.


Rapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cells.

Dago AE, Stepansky A, Carlsson A, Luttgen M, Kendall J, Baslan T, Kolatkar A, Wigler M, Bethel K, Gross ME, Hicks J, Kuhn P.

PLoS One. 2014 Aug 1;9(8):e101777. doi: 10.1371/journal.pone.0101777. eCollection 2014.


Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.

Bellas C, García D, Vicente Y, Kilany L, Abraira V, Navarro B, Provencio M, Martín P.

PLoS One. 2014 Jun 2;9(6):e98169. doi: 10.1371/journal.pone.0098169. eCollection 2014.


Non-IG aberrations of FOXP1 in B-cell malignancies lead to an aberrant expression of N-truncated isoforms of FOXP1.

Rouhigharabaei L, Finalet Ferreiro J, Tousseyn T, van der Krogt JA, Put N, Haralambieva E, Graux C, Maes B, Vicente C, Vandenberghe P, Cools J, Wlodarska I.

PLoS One. 2014 Jan 9;9(1):e85851. doi: 10.1371/journal.pone.0085851. eCollection 2014.


Downregulation of FOXP1 is required during germinal center B-cell function.

Sagardoy A, Martinez-Ferrandis JI, Roa S, Bunting KL, Aznar MA, Elemento O, Shaknovich R, Fontán L, Fresquet V, Perez-Roger I, Robles EF, De Smedt L, Sagaert X, Melnick A, Martinez-Climent JA.

Blood. 2013 May 23;121(21):4311-20. doi: 10.1182/blood-2012-10-462846. Epub 2013 Apr 11.


Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.

Su Y, Nielsen D, Zhu L, Richards K, Suter S, Breen M, Motsinger-Reif A, Osborne J.

Hum Genomics. 2013 Jan 5;7:2. doi: 10.1186/1479-7364-7-2.


NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Kashuba V, Dmitriev AA, Krasnov GS, Pavlova T, Ignatjev I, Gordiyuk VV, Gerashchenko AV, Braga EA, Yenamandra SP, Lerman M, Senchenko VN, Zabarovsky E.

Int J Mol Sci. 2012 Oct 18;13(10):13352-77. doi: 10.3390/ijms131013352.


Solution structure and backbone dynamics of the DNA-binding domain of FOXP1: insight into its domain swapping and DNA binding.

Chu YP, Chang CH, Shiu JH, Chang YT, Chen CY, Chuang WJ.

Protein Sci. 2011 May;20(5):908-24. doi: 10.1002/pro.626. Epub 2011 Apr 11.


Integrative genomic profiling of human prostate cancer.

Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL.

Cancer Cell. 2010 Jul 13;18(1):11-22. doi: 10.1016/j.ccr.2010.05.026. Epub 2010 Jun 24.


New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008.

van Krieken JH.

J Hematop. 2008 Sep;1(2):145-60. doi: 10.1007/s12308-008-0012-x. No abstract available.


Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Bende RJ, van Maldegem F, van Noesel CJ.

Haematologica. 2009 Aug;94(8):1109-23. doi: 10.3324/haematol.2009.005983. Epub 2009 Jul 16. Review.

Supplemental Content

Support Center